CTI |
Composite tissue injuries |
(DAMPs) |
Damage-associated molecular patterns |
TNF-α |
Tumor necrosis factor-alpha |
CCL2 |
Monocyte chemoattractant protein-1, MCP-1 |
IL |
Interleukin |
CCL3 |
Chemokine ligand 3 |
CD |
Cluster of differentiation |
IFN |
Interferon |
TGF |
Transforming growth factor |
Tregs |
Regulatory T cells |
AMPK 5′ |
Adenosine monophosphate-activated protein kinase |
IGF-1 |
Insulin-like growth factor 1 |
PDGF |
Platelet-derived growth factor |
VEGF-α |
Vascular endothelial growth factor α |
PDL1 |
Programmed cell death ligands 1 |
FAP cells |
Fibro-adipogenic progenitor cells |
CXCR |
Chemokine receptor |
Bcl-2 |
B-cell lymphoma 2 |
MCL1 |
Induced myeloid leukemia cell differentiation protein |
LTB4 |
Leukotriene 4 |
NETs |
Neutrophil extracellular traps |
ROS |
Reactive oxygen species |
MIP |
Macrophage inflammatory protein-1α |
LDNs |
Low-density neutrophils |
iNKT |
Invariant NKT |
Tie2 |
Angiopoietin-2 receptor |
1CTP |
Pyridinoline cross-linked carboxy-terminal telopeptide |
MCSF-1 |
Macrophage colony-stimulating factor |
DC |
Dendritic cells |
Areg |
Amphiregulin |
EGF |
Epidermal growth factor |
mTOR |
Mammalian target of rapamycin |
GCN2 |
General control nonderepressible 2 |
TCR |
T-cell receptor |
PTEN |
Phosphatase and tensin homolog |
PI3K |
Phosphoinositide 3-kinase |
IDO |
Indoleamine 2,3-dioxygenase |